Donor-specific pathological features associate with genetic background, lesion type distribution, and clinical heterogeneity in multiple sclerosis - Summary - MDSpire

Donor-specific pathological features associate with genetic background, lesion type distribution, and clinical heterogeneity in multiple sclerosis

  • By

  • Lukas Lütje

  • J. Q. Alida Chen

  • Jörg Hamann

  • Joost Smolders

  • Inge Huitinga

  • Aletta M. R. van den Bosch

  • June 25, 2026

  • 0 min

Share

Objective:

To investigate whether donor-specific pathological features in MS reflect biological processes associated with genetics, lesion patterns, and clinical disease course.

Approach:
  • Study Cohort: Utilized a well-characterized Netherlands Brain Bank MS autopsy cohort (NBB-MS) comprising 287 donors with confirmed MS pathology.
  • Tissue Sampling: Post-mortem brain tissue was dissected from standardized locations, with lesions identified macroscopically and through MRI.
  • Histopathological Analysis: Tissue blocks were double-immunostained to visualize activated microglia/macrophages and myelin, and lesions were classified based on inflammatory activity and myelin status.
  • Donor Stratification: Donors were stratified based on the presence of pathological features such as perivascular cuffs, microglial nodules, broad rim lesions, and remyelination efficiency.
Key Findings:
  • Substantial inter-individual heterogeneity in MS was observed, influenced by donor-specific pathological features.
  • Higher lesion load and mixed lesions correlate with faster disability accumulation.
  • Pathological features may reflect persistent inflammatory and reparative processes in MS.
Interpretation:

Limitations:
  • Exclusion of donors with relevant neurological or systemic comorbidities may limit generalizability.
  • Only donors with Braak scores ≤ 3 were included, potentially affecting the findings.
Conclusion:

Original Source(s)

Related Content